Effects of Long-term Exercise on Various Parameters in Heavy Drinkers

January 26, 2016 updated by: Athanasios Z. Jamurtas, University of Thessaly

Effects of Long-term Exercise on Psychological, Physiological, Biochemical and Alcohol-related Parameters in Heavy Drinkers

The purpose of this research is to examine the effects of long-term aerobic exercise of moderate intensity on psychological, physiological, biochemical, physiological and alcohol-related parameters in heavy drinkers, in order to investigate possible biochemical mechanisms by which exercise may be a healthy alternative to alcohol abuse.

Study Overview

Detailed Description

The mechanism of incentives that lead people to unhealthy habits such as excessive alcohol consumption is not only social, personal, and psychological, but also associated with neurochemical and neurobiological mechanisms.

Several programs have been developed to stop excessive drinking, but the success rates are small, while the relapse rates are very high, reaching up to 90%. Although there is some evidence for the beneficial effects of exercise on alcohol use disorders, research is limited. The present study investigates whether exercise can act as adjunct therapy for alcohol abuse cessation.

One of the basic assumptions is that the appropriate form of exercise in alcoholics will contribute to the secretion of beta-endorphin, which in combination with psychological pleasure, vitality, change of mood, reduced stress, increased confidence, and the shift of attention will help people to follow healthy lifestyles and abhor alcohol.

The research project is divided in three phases. In the first phase, the effect of acute exercise in critical psychological, physiological, biochemical and alcohol-related parameters associated with excessive alcohol consumption will be examined. In the second phase (current study), a long-term exercise program in conjunction with psychological support strategies aimed at alcohol abuse cessation will be developed, implemented and evaluated. Finally, in the third phase, based on the results of the previous phases, awareness programs in adolescent and adult populations will be designed and implemented as well as the dissemination of results and evaluation of the project will take place.

Study Type

Interventional

Enrollment (Actual)

13

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men drinking >14 drinks/week or >4 drinks/occasion; Women drinking >7 drinks/week or >4 drinks/occasion (1 drink = 14 grams of pure alcohol; definition of the NIAAA for drinking at low risk for developing an AUD; NIAAA, 2014)
  • Individuals drinking 5 or more drinks on the same occasion on each of 5 or more days in the past 30 days (1 drink = 14 grams of pure alcohol; definition of the Substance Abuse and Mental Health Services Administration for heavy drinking; NIAAA, 2014) Alcohol Use Disorders Identification Test (AUDIT) score>8

Exclusion Criteria:

  • Medical conditions or medication use that would preclude participation in aerobic exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control condition
Control condition with no intervention. Participants will be recording their daily alcohol consumption. No lifestyle modification during this period.
Experimental: Exercise training program
Supervised 8-week exercise training program. Aerobic exercise (walking, jogging) of increasing duration at 50-60% HRR, at least two sessions per week.
Supervised 8-week exercise training program. Aerobic exercise (walking, jogging) of increasing duration at 50-60% HRR, at least two sessions per week. Participants will be recording their daily alcohol consumption. Participants will also undergo three trials of acute exercise (before, at the 4th week and at the 8th week of exercise training) in order to investigate whether exercise training can lead to changes in acute responses to exercise. Each trial involves 30 min of exercise on a cycle ergometer at 50-60% HRR.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in alcohol consumption (grams of alcohol consumed weekly)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Self-recorded
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Changes in Beta-endorphin levels
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured by radioimmunoassay (RIA)
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Urge to drink
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
According to questionnaire
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Cortisol
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured by radioimmunoassay (RIA)
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Adrenocorticotrophic hormone (ACTH)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured by radioimmunoassay (RIA)
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Catecholamines (epinephrine, norepinephrine, dopamine)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured by radioimmunoassay (RIA)
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
C-reactive protein (CRP)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Semi-quantitative estimation with CRP Latex test kit
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Complete blood count
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Autoanalyzer Autoanalyzer Autoanalyzer
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Lactic acid
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured using photometry
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Erythrocyte sedimentation rate (ESR)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Wintrobe Method
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
γ-Glutamyltransferase (GGT)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured with commercial kit
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Aspartate Aminotransferase (AST)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured with commercial kit
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Alanine Aminotransferase (ALT)
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Measured with commercial kit
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Sit and reach flexibility test for the hamstrings muscles and lower back
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Each participant sits on the floor with legs stretched out straight ahead, reaches out and holds that position for at 1-2 seconds while the distance is recorded.
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Grip strength
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Handgrip strength test
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Number of push-ups performed in one minute
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
Number of sit-ups performed until exhaustion
Time Frame: At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention
At baseline and at 4th week of control condition; at baseline (before intervention), at 4th week and at 8th week of intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Chair: Yannis Theodorakis, PhD, University of Thessaly

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (Actual)

July 1, 2014

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

January 18, 2016

First Submitted That Met QC Criteria

January 26, 2016

First Posted (Estimate)

January 27, 2016

Study Record Updates

Last Update Posted (Estimate)

January 27, 2016

Last Update Submitted That Met QC Criteria

January 26, 2016

Last Verified

January 1, 2016

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Alcohol Use Disorder

Clinical Trials on Exercise training program

3
Subscribe